Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

mSphere(2020)10.1128/msphere.00622-20Source: DataRank Database

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity is a research paper published in mSphere (2020). On theSindex it has a DataRank of 0. It has been cited 42 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access42 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.07)OA: goldTopics (70)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Caroline Atyeo ORCID,Stephanie Fischinger ORCID,John S. Burke ORCID,Matthew D. Slein ORCID,Hendrik Streeck ORCID

Live enrichment

PubMed:32878931 PMC:PMC7471005 OpenAlex:https://openalex.org/W3081974864

HHS | National Institutes of Health

Grant: 3R37AI080289-11S1

Defining humoral correlates of immunity against COVID-19

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: U19 AI135995

HHS | Centers for Disease Control and Prevention

Grant: U01CK000490

NIAID NIH HHS

Grant: R37 AI080289

National Institutes of Health

Grant: 3U19AI135995-04S3

Consortium for Viral Systems Biology (CViSB)

National Institutes of Health

Grant: 5U01CK000490-03

Global TravEpiNet (GTEN): the Heading Home Healthy Program and Global Travelers' Health National Research Center Consortium, Guidance and Outreach Programs

FWCI

1.07

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

goldLicense: cc-by

journalhttps://doi.org/10.1128/msphere.00622-20

publisherhttps://doi.org/10.1128/msphere.00622-20

publisherhttps://journals.asm.org/doi/pdf/10.1128/mSphere.00622-20

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32878931

repositoryhttps://doaj.org/article/d055acc5916d4b90b38ae24bc3bbd195

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies0301 basic medicine03 medical and health sciencesAntibodies, ViralBetacoronavirusBiomarkersCOVID-19COVID-19 TestingClinical Laboratory TechniquesCoronavirus InfectionsCross ReactionsHumansImmunity, HeterologousImmunity, HumoralPandemicsPneumonia, ViralSARS-CoV-2

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 TestingAntibodies, ViralCross ReactionsHumansPneumonia, ViralBiomarkersCoronavirus InfectionsClinical Laboratory TechniquesImmunity, HumoralPandemicsImmunity, Heterologous

Keywords

ImmunityBiologyCoronavirusImmunologyVirologyImmune systemAcquired immune systemViral sheddingVirusAsymptomaticDiseaseInfectious disease (medical specialty)MedicineCoronavirus disease 2019 (COVID-19)Internal medicineAntibody responsecross-reactivitySars-cov-2Fc-receptor BindingClinical Laboratory TechniquesPneumonia, ViralMedizinCOVID-19Cross ReactionsAntibodies, ViralImmunity, HeterologousMicrobiologyQR1-502Immunity, HumoralBetacoronavirusCOVID-19 TestingHumansCoronavirus InfectionsMolecular BiologyPandemicsBiomarkersResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

FAIR Checklist

Authors (10)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)